(Q50110136)

25 February 2018

title

Pretreatment prostate-specific antigen values in patients with prostate cancer: 1989 patterns of care study process survey (English)

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)02013-X

31 May 2024

1

T. Teshima

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591887

31 May 2024

author name string

A. M. Hanlon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591887

31 May 2024

G. E. Hanks

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591887

31 May 2024

language of work or name

English

0 references

publication date

1 November 1995

1 reference

25 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:036030169502013X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)02013-X

https://api.elsevier.com/content/article/PII:036030169502013X?httpAccept=text/plain

31 May 2024

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)02013-X

International Journal of Radiation Oncology Biology Physics

31 May 2024

published in

1 reference

25 February 2018

volume

33

1 reference

25 February 2018

issue

4

1 reference

25 February 2018

page(s)

809-814

1 reference

25 February 2018

Prostate-specific antigen kinetics after external beam irradiation for carcinoma of the prostate

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)02013-X

Patterns of care outcome studies. Results of the national practice in cancer of the cervix

31 May 2024

5

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)02013-X

Summary results from the Facilities Master List surveys conducted by the Patterns of Care Study

31 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)02013-X

Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis

31 May 2024

10

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)02013-X

Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer

31 May 2024

11

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)02013-X

The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985)

31 May 2024

12

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)02013-X

Prostate Specific Antigen in the Management of Patients with Localized Adenocarcinoma of the Prostate Treated with Primary Radiation Therapy

31 May 2024

13

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)02013-X

The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy

31 May 2024

17

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)02013-X

Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome

31 May 2024

18

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)02013-X

31 May 2024

Identifiers

1 reference

25 February 2018

1 reference

25 February 2018